1. Home
  2. FSLY vs BLLN Comparison

FSLY vs BLLN Comparison

Compare FSLY & BLLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fastly Inc.

FSLY

Fastly Inc.

HOLD

Current Price

$25.89

Market Cap

3.5B

Sector

Technology

ML Signal

HOLD

BLLN

BillionToOne Inc.

N/A

Current Price

$75.98

Market Cap

3.9B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
FSLY
BLLN
Founded
2011
2016
Country
United States
United States
Employees
N/A
713
Industry
Computer Software: Prepackaged Software
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.9B
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
FSLY
BLLN
Price
$25.89
$75.98
Analyst Decision
Hold
Buy
Analyst Count
8
7
Target Price
$18.00
$126.71
AVG Volume (30 Days)
12.1M
380.2K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
N/A
EPS Growth
27.19
N/A
EPS
N/A
N/A
Revenue
$624,018,000.00
N/A
Revenue This Year
$16.39
$46.29
Revenue Next Year
$10.73
$30.14
P/E Ratio
N/A
N/A
Revenue Growth
14.78
N/A
52 Week Low
$5.63
$61.96
52 Week High
$34.82
$138.70

Technical Indicators

Market Signals
Indicator
FSLY
BLLN
Relative Strength Index (RSI) 51.39 44.25
Support Level $24.61 $64.99
Resistance Level $27.35 $83.20
Average True Range (ATR) 2.71 6.19
MACD -0.30 -0.86
Stochastic Oscillator 55.21 6.85

Price Performance

Historical Comparison
FSLY
BLLN

About FSLY Fastly Inc.

Fastly Inc is a cloud computing company that provides an edge cloud platform designed to deliver, secure, and optimize digital experiences over the internet. The company operates a unified platform that combines content delivery, edge computing, and security capabilities. Its services include content delivery networks, web and API protection, distributed denial of service mitigation, and real-time data processing at the edge. Its platform enables customers to improve the performance, scalability, and security of applications and digital content, and also supports cloud-native architectures, AI-driven workloads, and programmable edge computing solutions.

About BLLN BillionToOne Inc.

BillionToOne Inc is a molecular diagnostics company. It offers a portfolio of ultrasensitive tests covering prenatal genetic testing, cancer therapy selection, and response monitoring, which are based on its Quantitative Counting Templates (QCT) molecular counting platform. The company's product portfolio comprises UNITY, a portfolio of prenatal testing products that can conduct fetal risk analysis without requiring a paternal sample; Northstar Select, a ultrasensitive liquid biopsy test that provides insights into appropriate therapies for stage III or IV cancer patients; and Northstar Response, a tissue-free, pan-cancer, liquid biopsy test that measures several genomic loci uniquely methylated in cancer to provide insight into dynamic changes in therapy response.

Share on Social Networks: